Your account is not claimed yet. You can sign up with ORCID to claim your account.

Murat Araz

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Medical oncology (Northwood, London, England)

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Necmettin Erbakan University Meram Faculty of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Necmettin Erbakan University Meram Faculty of Medicine Oct 5o 2018

Turkey

Assistant Professor :: Medical Oncology

Publications

Mustafa Korkmaz, Melek Karakurt Eryılmaz, Muhammed Muhiddin Er, Mehmet Zahid Koçak, Aykut Demirkıran, Mustafa Karaağaç, Murat Araz, Mustafa Yıldırım, Zahid Mehmet Koçak
Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy? Journal of gastrointestinal cancer (2023)
Tuba Karaçelik, Buğra Kaya, Mustafa Korkmaz, Mustafa Karaağaç, Murat Araz, Melek Karakurt Eryılmaz, Hakan Şat Bozcuk, Mustafa Yıldırım
Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal Cancer. Journal of gastrointestinal cancer (2022)
Murat Araz, Melek Karakurt Eryilmaz
Immunotherapy era in the treatment of small cell lung cancer. Medical oncology (Northwood, London, England) 38 (7) (2021)
Muzaffer Uğraklı, Murat Araz, Aykut Demirkıran, Ahmet Faruk Çelik, Melek Karakurt Eryılmaz, Mustafa Karaağaç, Mustafa Yıldırım
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (3) (2021)
Tuba Karpuz, Murat Araz, Levent Korkmaz, Ibrahim Kılınc, Sidika Findik, Mustafa Karaagaç, Melek Karakurt Eryilmaz, Mehmet Artac
The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer. Journal of gastrointestinal cancer 51 (2) (2021)
Ismail Beypinar, Hacer Demir, Murat Araz, Meltem Baykara, Nuri Faruk Aykan
The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer. Journal of gastrointestinal cancer (2020)
Murat Araz, Mustafa Karaagac, Levent Korkmaz, Lokman Koral, Fatih Inci, Ismail Beypinar, Mukremin Uysal, Mehmet Artac
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study. Cancer chemotherapy and pharmacology 83 (6) (2019)

Murat Araz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Murat Araz